Dr. Kathryn Henick is a medical oncology specialist in Los Angeles, California and he works at several hospitals in the area, including Veterans Affairs Greater Los Angeles Healthcare System and UCLA Medical Center. She got his diploma from Medical College of Pennsylvania and completed his residency program in internal medicine at UCLA Medical Center, where he also did a fellowship in hematology/oncology. The doctor is certified in hematology and medical oncology and has an experience of more than 20 years.
Dr. Kathryn Henick has contributed to 2 publications.
A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease.
Berenson, J. R., Vescio, R., Henick, K., Nishikubo, C., Rettig, M., Swift, R. A., Conde, F., Von Teichert, J. M.; Cancer. 2001 Jan 1.
Dr. Kathryn Henick is a medical oncology specialist in Los Angeles, California and he works at several hospitals in the area, including Veterans Affairs Greater Los Angeles Healthcare System and UCLA Medical Center. She got his diploma from Medical College of Pennsylvania and completed his residency program in internal medicine at UCLA Medical Center, where he also did a fellowship in hematology/oncology. The doctor is certified in hematology and medical oncology and has an experience of more than 20 years.
Dr. Kathryn Henick has contributed to 2 publications.
A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease.
Berenson, J. R., Vescio, R., Henick, K., Nishikubo, C., Rettig, M., Swift, R. A., Conde, F., Von Teichert, J. M.; Cancer. 2001 Jan 1.
Hospitals & Clinics
specialties & services
